Leukaemic cells in patients with type A NPM1 mutation strongly expressed myeloperoxidase (MPO) and CD33 with dim expression of other myelomonocytic antigens commonly expressed in AML including CD13, CD65, CD15, and CD14. The gene discussed is NPM1; the disease is acute myeloid leukemia.